晚期肺癌中医用药规律研究进展

Research Progress on the Rule of TCM Drug Use in Advanced Lung Cancer

肺癌是世界常见的恶性肿瘤之一,在中国其发病率和死亡率位居癌症之首,且肺癌症状隐匿,被确诊时70%~80%为晚期。晚期肺癌患者面临失去手术机会、无法耐受放化疗及耐药等不利情况,而中医药在提高晚期肺癌患者的生活质量、延长生存期及化疗时增效减毒等方面疗效显著。现对近5年晚期肺癌的中医病因、病机及中医内治法的治疗规律进行综述,以期为中药治疗晚期肺癌提供思路和依据。

Lung cancer is one of the most common malignant tumors in the world,with the highest incidence and mortality of cancer in China.Lung cancer has hidden symptoms,and 70%to 80%of lung cancer is advanced when diagnosed.Patients with advanced lung cancer face the disadvantage of losing the opportunity of surgery,being unable to tolerate chemoradiotherapy and drug resistance,while Chinese medicine has a significant effect on improving the quality of life,prolonging the survival period and enhancing the efficacy and reducing the toxicity of chemotherapy in patients with advanced lung cancer.In this paper,the etiology,pathogenesis and internal treatment of advanced lung cancer in TCM were reviewed in the past five years,in order to provide ideas and basis for TCM treatment of advanced lung cancer.